Tapentadol Krka is indicated for the management of severe chronic pain in adults, which can be adequately managed only with opioid analgesics.
Ranolazine Krka is indicated in adults as add-on therapy for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled or intolerant to first-line antianginal therapies (such as beta-blockers and/or calcium antagonists).
The National Institute for Health and Care Exellence (NICE) has recommended, once daily, Rezolsta (darunavir + cobicistat) from Janssen for...
The purpose of this study is to evaluate the single-dose pharmacokinetics and bioequivalence of darunavir 800 mg when administered as...
The FDA has approved Prezcobix (darunavir 800 mg/cobicistat 150 mg) tablets, from Janssen Therapuetics, for the treatment of Human Immunodeficiency...
Janssen R&D has submitted a New Drug Application to the FDA seeking approval for a once-daily fixed-dose antiretroviral combination tablet...